Loading…
Very late relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation
Abstract Allogeneic stem cell transplantation is considered to be a curative treatment modality in patients with chronic myelogenous leukemia. However patients are at risk for relapse years after transplantation. Currently we present two patients who relapsed 16 and 24 years after allogeneic bone ma...
Saved in:
Published in: | Leukemia research 2009-09, Vol.33 (9), p.1291-1293 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Abstract Allogeneic stem cell transplantation is considered to be a curative treatment modality in patients with chronic myelogenous leukemia. However patients are at risk for relapse years after transplantation. Currently we present two patients who relapsed 16 and 24 years after allogeneic bone marrow transplantation, respectively. These patients emphasize the need for long term follow-up of such patients. |
---|---|
ISSN: | 0145-2126 1873-5835 |
DOI: | 10.1016/j.leukres.2009.03.010 |